These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 17121795)
1. Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. Leclerc D; Beauseigle D; Denis J; Morin H; Paré C; Lamarre A; Lapointe R J Virol; 2007 Feb; 81(3):1319-26. PubMed ID: 17121795 [TBL] [Abstract][Full Text] [Related]
2. A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling. Thérien A; Bédard M; Carignan D; Rioux G; Gauthier-Landry L; Laliberté-Gagné MÈ; Bolduc M; Savard P; Leclerc D J Nanobiotechnology; 2017 Jul; 15(1):54. PubMed ID: 28720097 [TBL] [Abstract][Full Text] [Related]
3. Two distinct chimeric potexviruses share antigenic cross-presentation properties of MHC class I epitopes. Hanafi LA; Bolduc M; Gagné ME; Dufour F; Langelier Y; Boulassel MR; Routy JP; Leclerc D; Lapointe R Vaccine; 2010 Aug; 28(34):5617-26. PubMed ID: 20600515 [TBL] [Abstract][Full Text] [Related]
4. MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy. Possamaï D; Hanafi LA; Bellemare-Pelletier A; Hamelin K; Thébault P; Hébert MJ; Gagnon É; Leclerc D; Lapointe R PLoS One; 2021; 16(12):e0261987. PubMed ID: 34972158 [TBL] [Abstract][Full Text] [Related]
5. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions. Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945 [TBL] [Abstract][Full Text] [Related]
6. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Denis J; Acosta-Ramirez E; Zhao Y; Hamelin ME; Koukavica I; Baz M; Abed Y; Savard C; Pare C; Lopez Macias C; Boivin G; Leclerc D Vaccine; 2008 Jun; 26(27-28):3395-403. PubMed ID: 18511159 [TBL] [Abstract][Full Text] [Related]
7. [Molecular basis for detection of infectious agents]. Siegrist CA Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322 [TBL] [Abstract][Full Text] [Related]
13. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546 [TBL] [Abstract][Full Text] [Related]
14. High avidity binding of engineered papaya mosaic virus virus-like particles to resting spores of Plasmodiophora brassicae. Morin H; Tremblay MH; Plante E; Paré C; Majeau N; Hogue R; Leclerc D J Biotechnol; 2007 Feb; 128(2):423-34. PubMed ID: 17126944 [TBL] [Abstract][Full Text] [Related]
15. Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP]. Savard C; Laliberté-Gagné MÈ; Babin C; Bolduc M; Guérin A; Drouin K; Forget MA; Majeau N; Lapointe R; Leclerc D Vaccine; 2012 Mar; 30(15):2535-42. PubMed ID: 22326774 [TBL] [Abstract][Full Text] [Related]
16. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757 [TBL] [Abstract][Full Text] [Related]
17. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589 [TBL] [Abstract][Full Text] [Related]
18. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
19. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584 [TBL] [Abstract][Full Text] [Related]
20. Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity. Laliberté-Gagné ME; Bolduc M; Garneau C; Olivera-Ugarte SM; Savard P; Leclerc D Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33435570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]